LianBio ADR Valuation
| LIANDelisted Stock | USD 2.18 0.05 2.24% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. LianBio ADR secures a last-minute Real Value of $1.98 per share. The latest price of the firm is $2.18. Our model forecasts the value of LianBio ADR from analyzing the firm fundamentals such as Current Valuation of (182.65 M), shares owned by insiders of 5.90 %, and Return On Equity of -0.32 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that LianBio ADR's price fluctuation is very steady at this time. Calculation of the real value of LianBio ADR is based on 3 months time horizon. Increasing LianBio ADR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since LianBio ADR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LianBio Stock. However, LianBio ADR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.18 | Real 1.98 | Hype 2.18 |
The intrinsic value of LianBio ADR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LianBio ADR's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of LianBio ADR helps investors to forecast how LianBio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LianBio ADR more accurately as focusing exclusively on LianBio ADR's fundamentals will not take into account other important factors: LianBio ADR Total Value Analysis
LianBio ADR is now forecasted to have valuation of (182.65 M) with market capitalization of 34.47 M, debt of 4.34 M, and cash on hands of 329.3 M. The negative valuation of LianBio ADR may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the LianBio ADR fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(182.65 M) | 34.47 M | 4.34 M | 329.3 M |
LianBio ADR Asset Utilization
One of the ways to look at asset utilization of LianBio is to check how much profit was generated for every dollar of assets it reports. LianBio ADR secures a negative usage of assets of -0.22 %, losing $0.002167 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of LianBio ADR shows how discouraging it operates for each dollar spent on its assets.LianBio ADR Ownership Allocation
LianBio ADR maintains a total of 108.06 Million outstanding shares. The majority of LianBio ADR outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LianBio ADR to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in LianBio ADR. Please pay attention to any change in the institutional holdings of LianBio ADR as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.LianBio ADR Profitability Analysis
Net Loss for the year was (87.98 M) with profit before overhead, payroll, taxes, and interest of 0.About LianBio ADR Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of LianBio ADR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of LianBio ADR based exclusively on its fundamental and basic technical indicators. By analyzing LianBio ADR's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of LianBio ADR's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of LianBio ADR. We calculate exposure to LianBio ADR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LianBio ADR's related companies.LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.
LianBio ADR Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 107.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |